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Generation and Expression of a Hoxa11eGFP
Targeted Allele in Mice
Lisa T. Nelson,1 Sabita Rakshit,1 Hanshi Sun,1 and Deneen M. Wellik1,2*
Hox genes are crucial for body axis specification during embryonic development. Hoxa11 plays a role in
anteroposterior patterning of the axial skeleton, development of the urogenital tract of both sexes, and
proximodistal patterning of the limbs. Hoxa11 expression is also observed in the neural tube. Herein, we
report the generation of a Hoxa11eGFP targeted knock-in allele in mice in which eGFP replaces the first
coding exon of Hoxa11 as an in-frame fusion. This allele closely recapitulates the reported mRNA expression
patterns for Hoxa11. Hoxa11eGFP can be visualized in the tail, neural tube, limbs, kidneys, and
reproductive tract of both sexes. Additionally, homozygous mutants recapitulate reported phenotypes for
Hoxa11 loss of function mice, exhibiting loss of fertility in both males and females. This targeted mouse line
will prove useful as a vital marker for Hoxa11 protein localization during control (heterozygous) or mutant
organogenesis. Developmental Dynamics 237:3410–3416, 2008. © 2008 Wiley-Liss, Inc.
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INTRODUCTION
Hox genes were first described in Dro-
sophila and are homeodomain con-
taining transcription factors that play
a role in body axis specification during
embryonic development (Wellik, 2007).
In mammals, there are 39 Hox genes
arranged in four clusters, A, B, C, and
D, which have arisen through duplica-
tions of an ancestral cluster during
evolution. Based on sequence similar-
ity, these clusters can be aligned into
13 paralogous groups, with Hox1 lo-
cated most 3 on the chromosome and
Hox13 most 5. During development,
the Hox genes are expressed colin-
early along the primary body axis
with 3 genes expressed earlier and
with more anterior limits, and more 5
genes expressed later with increas-
ingly posterior boundaries. Members
of each paralogous group exhibit sim-
ilar expression patterns along the
anterioposterior (AP) axis and are
functionally redundant in many de-
velopmental processes. (Condie and
Capecchi, 1994; Davis et al., 1995; Ho-
ran et al., 1995; Fromental-Ramain et
al., 1996; Warot et al., 1997; van den
Akker et al., 2001; Wellik et al., 2002;
Wellik and Capecchi, 2003; McIntyre
et al., 2007).
In mice, expression patterns for
Hoxa11 mRNA have been previously
reported. Faint expression is first de-
tected at approximately E9.0 in the
posterior tip of the embryo. By E10.5,
expression in the tail has increased in
intensity and expression is also ob-
served in all four limb buds (Small
and Potter, 1993). As limb bud
morphogenesis proceeds, the mRNA
expression pattern undergoes well
documented, dynamic changes. The
expression is concentrated in the dis-
tal limb bud until approximately E11
(Peichel et al., 1997), then becomes
localized to the developing zeugopod
region at subsequent stages (Haack
and Gruss, 1993; Hsieh-Li et al.,
1995). In the developing kidney,
Hoxa11 expression has been reported
in the metanephric blastema before
ureteric bud induction (Patterson et
al., 2001), and later, expression is re-
stricted to the nephrogenic mesen-
chyme during stages of branching
1Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor,
Michigan
2Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan
Grant sponsor: NIH; Grant number: DK071929; Grant number: DK077045.
*Correspondence to: Deneen M. Wellik, University of Michigan Medical Center, 109 Zina Pitcher Place, 2053 BSRB, Ann
Arbor, MI 48109-2200. E-mail: dwellik@umich.edu
DOI 10.1002/dvdy.21756
Published online 15 October 2008 in Wiley InterScience (www.interscience.wiley.com).
DEVELOPMENTAL DYNAMICS 237:3410–3416, 2008
© 2008 Wiley-Liss, Inc.
morphogenesis (Patterson et al.,
2001). In the adult reproductive sys-
tem, Hoxa11 expression has been doc-
umented in the uterus in females and
in the vas deferens in males (Hsieh-Li
et al., 1995).
Loss of function of Hoxa11 in the
developing embryo results in rela-
tively mild malformations in the axial
and appendicular skeleton and defects
in the reproductive system of both
males and females (Small and Potter,
1993; Hsieh-Li et al., 1995; Gendron
et al., 1997; Wong et al., 2004). Mu-
tants of both sexes are infertile
(Hsieh-Li et al., 1995). Males exhibit
transformation of the vas deferens to
an epididymal fate, and the testis do
not descend. Mutant females have ap-
parently normal ovaries; however, the
uterine environment is unable to sup-
port implantation (Hsieh-Li et al.,
1995; Gendron et al., 1997; Wong et
al., 2004). Hoxa11 mutant mice have
no detectable kidney phenotype
(Hsieh-Li et al., 1995), but mutation of
two or more Hox11 group genes re-
sults in severe kidney defects (Davis
et al., 1995; Patterson et al., 2001;
Wellik et al., 2002).
We have generated a targeted
Hoxa11eGFP knock-in allele in mice.
The eGFP allows real-time visualiza-
tion of Hoxa11 expression in the de-
veloping embryo as well as in the
adult mouse. eGFP detection closely
follows what has been reported for
Hoxa11 mRNA expression (Haack and
Gruss, 1993; Small and Potter, 1993;
Hsieh-Li et al., 1995; Peichel et al.,
1997; Patterson et al., 2001), thus it
serves as an useful marker for Hoxa11
protein localization in vivo.
RESULTS AND DISCUSSION
Crosses between Hoxa11eGFP het-
erozygotes produced offspring in nor-
mal Mendelian ratios. Breeding
Hoxa11eGFP to homozygosity results
in infertility in both sexes, which fol-
lows the previously reported Hoxa11
mutant phenotype (Hsieh-Li et al.,
1995). Additionally, generation of tri-
ple heterozygous mice (Hoxa11eGFP
/; Hoxc11 /; Hoxd11 /) also
results in infertility as previously re-
ported (Wellik et al., 2002).
Whole-Mount Expression
Hoxa11eGFP localization is first ob-
served at approximately embryonic
day (E) 9.0, slightly later than the re-
ported mRNA expression pattern.
This is likely due to the time required
for mRNA translation into protein and
eGFP accumulation to detectable lev-
els. At E9.5, Hoxa11eGFP localization
is observed in the tip of the tail and
faintly in the emerging forelimb bud
(Fig. 1B). By E10.5, localization in the
forelimb is more intense and re-
stricted to the distal end of the bud. At
this stage, Hoxa11eGFP is also local-
ized in the emerging hindlimbs and in
the neural tube and flank mesoderm
from the mid-hindlimb region to the
posterior tip of the tail (Fig. 1D). Fi-
delity of the Hoxa11eGFP detection is
evident by comparison with the
Hoxa11 mRNA expression pattern ob-
served in whole-mount embryos (com-
pare Fig. 1C with 1D). After E11.5,
fluorescence becomes restricted to a
more proximal region of the develop-
ing limbs, and becomes less intense in
the autopod (Fig. 1F,H,J,L). Detection
in the tail peaks at E10.5 and de-
creases in intensity at later develop-
mental stages (Fig. 1D,F,H,J,L).
Hoxa11eGFP fluorescence can be de-
tected in the tail, neural tube and limb
buds in whole-mount animals through
newborn stages (Fig. 1L and data not
shown). Fluorescence is visible in
fresh, fixed and cryopreserved tissues
(see the Experimental Procedures sec-
tion). No fluorescence is detected in
wild-type embryos at the same set-
tings used to detect eGFP (Fig. 1I and
data not shown).
Limb Expression
Hoxa11eGFP localization in the limbs
closely follows the dynamic patterns
previously reported for mRNA expres-
sion (Haack and Gruss, 1993; Small
and Potter, 1993; Hsieh-Li et al.,
1995). Hoxa11eGFP is first detected
in the emerging forelimb buds at E9.5
(Fig. 1B). By E10.5, strong fluores-
cence is noted in both the forelimb and
hindlimb buds (Fig. 1D). At this stage,
localization appears to be throughout
most of the limb bud by whole-mount
analysis (Fig. 1D); however, section
analysis reveals that Hoxa11eGFP is
localized uniformly in all mesenchy-
mal cells of the distal limb bud, but
in only a subset of cells proximally
(Fig. 2A). Ubiquitous expression
throughout the distal limb bud re-
mains at E11.5, with a subset of cells
in the proximal limb bud maintaining
strong eGFP fluorescence (Fig. 2B).
Hoxa11eGFP is excluded from the
cells in the center of the proximal limb
(Fig. 2B). Co-staining at this stage
with antibodies to Sox9, a precartilag-
inous marker, reveals mutually exclu-
sive expression with Sox9 in the cen-
tral region of the limb bud. Only a
small band of colocalization is ob-
served toward the distal portion of
Sox9 expression (Fig. 2B). By E12.5,
Hoxa11eGFP becomes localized to the
developing zeugopod region with lower
levels of expression detected in the au-
topod (Fig. 2C). Hoxa11eGFP is ob-
served in the distal zeugopod region at
E13.5, and is detected more faintly in
the interdigital region of the autopod
(Fig. 2E). Co-staining with Sox9 at this
stage allows the condensing cartilage to
be visualized. Hoxa11eGFP and Sox9
appear to be co-expressed at the distal
ends of the developing radius and ulna,
but otherwise remain mutually ex-
clusive (Fig. 2E). At later stages,
Hoxa11eGFP is localized at the distal
zeugopod, where it is detected sur-
rounding the distal radius and ulna in
perichondrial regions (Fig. 2E,F). Rela-
tively faint localization in the interdigi-
tal mesenchyme of the autopod is ob-
served at E12.5 (Fig. 2C). At E15.5 and
beyond, Hoxa11eGFP expression in the
autopod becomes restricted to cells sur-
rounding the condensing digit cartilage
(Fig. 2F and data not shown). Compar-
ison of a wild-type control with a
Hoxa11eGFP limb section at E13.5
shows the relative background levels
for this allele (compare Fig. 2D with 2E,
no green fluorescence is detected at sim-
ilar settings in the absence of the
Hoxa11eGFP allele).
Urogenital Expression
In the early developing kidney,
Hoxa11eGFP can be detected through-
out the condensing metanephric mes-
enchyme and is never observed in the
ureteric bud or its derivatives (Fig.
3A,B). As tubulogenesis proceeds,
Hoxa11eGFP becomes localized to
the progenitor cells surrounding the
branching ureter tips and less in-
tensely in the mesenchyme surround-
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Fig. 1. Hoxa11eGFP fluorescence in whole-
mount embryos. A,B: Embryonic day (E) 9.5
Hoxa11eGFP heterozygous embryos showing
the brightfield view (A) and Hoxa11eGFP fluo-
rescence (B). C: Hoxa11 RNA in situ hybridiza-
tion on an E10.5 wild-type embryo. D: An E10.5
Hoxa11eGFP heterozygous embryo showing
eGFP fluorescence. E,F: E11.5 heterozygous
Hoxa11eGFP embryo showing the brightfield
view (E) and eGFP fluorescence (F). G,H: An
E12.5 Hoxa11eGFP heterozygous embryo with
the brightfield view (G) and eGFP fluorescence
(H). I: An E13.5 wild-type embryo on the green
fluorescence channel has no visible fluores-
cence at settings used for eGFP detection. J:
An E13.5 Hoxa11eGFP heterozygous embryo
showing eGFP fluorescence. K,L: An E15.5
Hoxa11eGFP heterozygous embryo with the
brightfield view (K) and eGFP fluorescence (L).
Arrowheads indicate regions of Hoxa11eGFP
expression in the limbs in each panel.
Fig. 2. Hoxa11eGFP localization in cryosec-
tions through the forelimbs at various stages of
development. A: A transverse section through a
Hoxa11eGFP heterozygous forelimb at embry-
onic day (E) 10.5. B: Transverse section of a
Hoxa11eGFP heterozygous forelimb at E11.5
co-stained with antibodies to Sox9, a prechron-
drogenic marker. C: A transverse section
through a Hoxa11eGFP heterozygous forelimb
at E12.5. D: A transverse section through an
E13.5 wild-type forelimb (no Hoxa11eGFP), us-
ing anti-Sox9 antibody staining (in red) and
green channel fluorescence at the same set-
tings as E. E: Transverse section through an
Hoxa11eGFP heterozygous E13.5 forelimb co-
stained with Sox9 in red. F: A transverse sec-
tion through a Hoxa11eGFP heterozygous fore-
limb at E15.5. Scale bar  500 microns in A–F.
ing the ureter (Fig. 3C,D). Co-stain-
ing with antibodies to Pax2 at E13.5, a
marker of nephrogenic mesenchyme
and ureteric bud, demonstrates par-
tially overlapping expression (Fig.
3D–F). Hoxa11eGFP and Pax2 are
both expressed in the nephrogenic
mesenchyme. Pax2 is exclusively ex-
pressed in the ureteric bud and its
derivatives and Hoxa11eGFP is exclu-
sively observed in the stromal mesen-
chyme surrounding the ureter. At
E15.0, Hoxa11eGFP is observed in the
nephrogenic mesenchyme and in mes-
enchymal cells surrounding the ure-
teric bud (Fig. 3G). Co-staining at E16.5
with peanut agglutinin (PNA), a collect-
ing tubule marker, reveals largely ex-
clusive expression with Hoxa11eGFP,
although some co-staining in convo-
luted tubules is apparent (Fig. 3H). Lo-
calization of Hoxa11eGFP in the neph-
rogenic progenitor cells is maintained
through approximately P8 and is not
visible after this stage (data not shown).
In the female reproductive tract,
Hoxa11eGFP is observed throughout
the uterus but not in the ovaries. Lo-
calization in the uterus is established
during the early differentiation of the
tissue (Fig. 4A) and remains high
throughout adulthood at all stages ex-
amined (Fig. 4C,E,G and data not
shown). In males, Hoxa11eGFP is
strongly expressed in the vas deferens
from embryonic stages (Fig. 4B)
through adulthood (Fig. 4D,F,H and
data not shown).
Neural Tube Expression
From the earliest stages of Hoxa11
expression, Hoxa11eGFP is observed
in the neural tube (Fig. 1B). By E11.5
Hoxa11eGFP is localized to ventrolat-
eral regions of the neural tube, corre-
lating with areas of motor neuron dif-
ferentiation (Fig. 5A). At E12.5 and
E13.5 Hoxa11eGFP is observed in
more dorsal and medial regions of the
neural tube (Fig. 5B,C). Control em-
bryos do not show GFP fluorescence at
similar fluorescent settings (Fig. 5D
and data not shown).
To summarize, we have generated a
novel Hoxa11eGFP targeted allele in
mice. This allele closely recapitulates
documented Hoxa11 mRNA expres-
sion patterns in the neural tube,
limbs, and urogenital system, con-
firming that it is a faithful reporter of
Hoxa11 expression. This mouse line
will be useful for studies of the dy-
namic Hoxa11 localization patterns
during both control (heterozygous)
and mutant development. Further-
more, the allele is stable in fresh as
well as fixed tissues, and therefore





Hoxa11eGFP Allele in Mice
BAC clone RP23-20F21 that spans the
entire HoxA complex was identified by
screening the RPCI-23 C57Bl/6 li-
brary (Osoegawa et al., 2000). A total
of 10 kb of genomic sequences includ-
ing coding sequence for Hoxa11, in-
Fig. 3. Hoxa11eGFP fluorescence in transverse cryosections of the developing kidney.
A: Hoxa11eGFP fluorescence in the condensing metanephric mesenchyme (arrows) of an embry-
onic day (E) 10.5 heterozygous embryo. B: Hoxa11eGFP heterozygous embryo at E11.5 with
fluorescing metanephric mesenchyme (arrows) being invaded by the ureteric bud (white asterisk),
which does not express Hoxa11eGFP. C: E12.5 kidney showing Hoxa11eGFP localized in the
condensing nephrogenic mesenchyme (arrow) surrounding the ureteric bud (white asterisk). D–F:
Hoxa11eGFP heterozygous kidney at E13.5 (D), co-stained with anti-Pax2 antibody (in red; E), and
colocalizations of Hoxa11eGFP and Pax2 in this section (F). Colocalization of Hoxa11eGFP and
Pax2 is observed in the condensing nephrogenic mesenchyme (arrow). The ureteric bud (white
asterisk) and ureteric bud-derived elements show only Pax2 expression, and mesenchyme sur-
rounding the ureter demonstrates only Hoxa11eGFP. G: In the E15.0 Hoxa11eGFP heterozygous
kidney, fluorescence is detected in the condensing nephrogenic mesenchyme cells (arrow) and in
mesenchyme surrounding the ureteric bud (white asterisk), which does not express the
Hoxa11eGFP allele. H: PNA, which labels early collecting tubules, is largely nonoverlapping with
Hoxa11eGFP at E16.5. Scale bars  200 microns in A–H.
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cluding 4.7 kb upstream of exon 1 and
0.7 kb downstream of exon 2 was sub-
cloned using recombineering technol-
ogy to an ASCL vector (Muyrers et al.,
1999, 2004; McIntyre et al., 2007). An
eGFP fluorescent fusion construct
(eGFP, Clontech) was exchanged as an
in-frame fusion 18 base pairs down-
stream of the start site in exon 1 of
Hoxa11; this recombination event re-
sulted in removal of most of exon 1. The
eGFP fusion protein is followed by a
SV40 poly-A strong stop signal, creating
a null allele, which expresses eGFP in
place of Hoxa11. Following the stop sig-
nal, there is a tACE-Cre-Neor (ACN)
construct in the opposite orientation
(Bunting et al., 1999). The Neor allows
for selection of the embryonic stem (ES)
cells after electroporation. The tACE-
Cre drives expression of Cre from the
testes-specific ACE promoter (Langford
et al., 1991) and allows removal of the
Cre and Neor sequences from the tar-
geted locus during chimeric passage to
germ line. The Cre coding sequence con-
tains the SV40 small antigen intron
which prevents leaky expression before
germ-line transmission (Bunting et al.,
1999). The ACN cassette is flanked by
LoxP sites, allowing Cre-mediated exci-
sion of the cassette. TK was inserted 5
to the genomic flanking sequence to pro-
vide positive selection and decrease
random transgenic insertions of the tar-
geting vector into nonhomologous re-
gions. (Fig. 1A shows a schematic of the
targeting vector.)
The Hoxa11eGFP targeting vector
was electroporated into R1 ES cells
Fig. 4.
Fig. 5.
Fig. 4. Hoxa11eGFP fluorescence in heterozy-
gous reproductive tracts from both sexes.
A,C,E,G: Dissected female reproductive tracts
at embryonic day (E) 16.5 (A), P1 (C), P28 (E),
and 10 months (G). Hoxa11eGFP is observed in
the developing uterus (arrows) and is excluded
from the ovaries. B,D,F,H: Dissected male re-
productive tracts at E16.5 (B), P1 (D), P28 (F),
and 10 months (H). Intense Hoxa11eGFP local-
ization is observed in the vas deferens (arrows).
K, kidney; O, ovary; T, testis.
Fig. 5. Hoxa11eGFP fluorescence in the neural
tube. A–C: Transverse cryosections through the
sacral region of the neural tube of Hoxa11eGFP
heterozygous embryos at embryonic day (E)
11.5 (A), E12.5 (B), and E13.5 (C). D: Transverse
cryosection through the sacral region of the
neural tube of a wild-type embryo at E13.5 pho-
tographed using the same fluorescence set-
tings as for C. Scale bar  200 microns in A–D.
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(Nagy et al., 1993), and double selec-
tion was performed with G418 and
FIAU (Mansour et al., 1988). Surviv-
ing clones were analyzed by Southern
analysis to identify homologous re-
combinants using a 5 flanking probe,
a 3 flanking probe and a Neor probe
with ApaL1 digested DNA (Fig. 6B
and data not shown). The 813-bp 5
probe was generated using primers 5-
GTA TTT GAA TTC GAT GCC GAA
CTG AGG CCA ATG GTT GT-3 and
5-AGC GTG TCT AGA GCT CTG
CAG CAG AGC CGG ATA GAA AC-3,
and the 621-bp 3 probe generated us-
ing primers 5-CTC CTT TTG AAT
TCG GAA TAG TCA GCG CTC TTG
GGA CCC ACT-3 and 5-GCA CTC
TGT CTA GAA GAG GAC ACA GGG
AAG CTG ACC AGG TAG-3, that
were randomly labeled with 32P-
dCTP. Two positive clones were iden-
tified and injected into blastocysts.
Twelve high-percentage, agouti chi-
meric founder males were generated
and several transmitted the allele, all
of which resulted in the removal of the
ACN cassette. Polymerase chain reac-
tion (PCR) analysis of tail DNA con-
firmed germ-line transmission of the
allele and deletion of the ACN cassette
(Fig. 6C). Three founder lines were
then back-crossed to C57Bl/6 mice. All
founder lines were found to be indis-
tinguishable in phenotype.
Genotyping was performed by PCR
using either tail or yolk sac DNA. The
following primers were used to detect
a 218-bp band for the wild-type allele,
and a 405-bp band for the eGFP allele:
Forward: 5-CTA CTT CAC GGA TCC
GCT TCA-3, Reverse: 5-GGT TGG
AGG AGT AGG AGT ATG-3, and
eGFP reverse: 5-ATG GTG CGC TCC




Embryos were collected at various
stages of gestation for analyses. After
dissection in PBS, they were fixed in
formalin or 4% paraformaldehyde.
Whole-mount images were taken on
the Olympus SZX9 florescent dissect-
ing microscope with an Olympus
DP70 camera or the Leica MXFL III
stereo fluorescent microscope with a
Sony DKC5000 video-to-digital cam-
era. After fixation, animals were
equilibrated in 15% and then 30% su-
crose, then embedded in Tissue-Tek
O.C.T. Compound embedding medium
on dry ice. Cryosections were cut at 16
m using a MICROM 500M Cryostat.
For co-staining, sections were washed
with PBSTw and blocked for 30 min
with 2% sheep serum. Polyclonal rab-
bit anti-Pax2 (Covance, PRB-276P)
was used in a 1:250 dilution, and poly-
clonal rabbit anti-Sox9 (Chemicon,
AB5535) in a 1:500 dilution. Sections
were incubated with primary antibody
overnight at 4°C, rinsed with PBSTw,
incubated with anti-rabbit TRITC (1:
300 dilution) for 2–3 hr at room tem-
perature, and rinsed with PBSTw.
Rhodamine peanut agglutinin (PNA)
(Vector Laboratories, RL-1072) was
incubated at room temperature (1:400
dilution) for three hours, after block-
ing, then rinsed with PBSTw. Pro-
Long Gold, antifade reagent (Invitro-
gen) was used for mounting. Images
were taken on either an Olympus
BX-51 upright light microscope with
an Olympus DP70 camera, or a Zeiss
LSM 510-META Laser Scanning Con-
focal Microscope mounted on a Zeiss
Axiovert 100M inverted microscope
using an argon laser. All green fluo-
rescence shown in figures are images
showing direct detection of fluores-




Embryos were treated as previously
described (Huppert et al., 2005). Im-
ages were taken on a Leica MZ125
dissecting microscope with a Leica
DFC480 camera.
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